Volume 26, Issue 127, September 2022

Leiomyosarcoma of uterus - A rare case presentation

Pragyamita Datta^1♦, Hiwale KM², Sunita Vagha³

¹M.D. Pathology Resident (1st year), JNMC (DMIMS), Jawaharlal Nehru Medical College, DMIMS (DU), Wardha, Maharashtra, India
²Professor, Department of Pathology, Jawaharlal Nehru Medical College, DMIMS (DU), Wardha, Maharashtra, India
³HOD, Department of Pathology, Jawaharlal Nehru Medical College, DMIMS (DU), Wardha, Maharashtra, India

^♦Corresponding author
M.D. Pathology Resident (1st year), JNMC (DMIMS), Jawaharlal Nehru Medical College, DMIMS (DU), Wardha, Maharashtra, India

ABSTRACT

A leiomyoma or uterine fibroid can develop into leiomyosarcoma, a malignant change. Two to five percent of all uterine tumors are caused by this uncommon tumor, which grows from the smooth muscle of the uterus. Rarely have cases in the past been described. Genital bleeding, a common sign of uterine sarcoma, had never happened to our patient (US). We offer a unique case study of a rare tumor that sprang from the uterus and manifested unusually. A 55-year-old woman with stomach pain that started out mildly and worsened was sent to the hospital. The discomfort was non-radiating, dull and agonizing, and it came and went. The patient also discovered a lump in his abdomen that appeared out of nowhere and grew larger. Using CECT, a mass that was protruding from the pelvic was found. The results of the histology study supported the diagnosis of uterine leiomyosarcoma. Due to their scarcity, the US is not acceptable for screening. The sole available form of treatment is surgery, and the diagnosis is made by histopathologic testing. The prognosis for women with uterine sarcoma is mostly influenced by the severity of the disease at the time of diagnosis and the mitotic index.

Keywords: Case report, Leiomyosarcoma, Rare tumor, Uterus

Medical Science, 2022, 26, ms377e2301

PDF

DOI: https://doi.org/10.54905/disssi/v26i127/ms377e2301

Published: 20 September 2022